Croix-Rousse Hospital, Lyon   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: France

Organization Overview

First Clinical Trial
2011
NCT01332955
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Croix-Rousse Hospital - Lyon-France | Departement of Pulmonology, Croix-Rousse Hospital, Hospices Civils de Lyon | Hopital Croix Rousse, Lyon | Hopital Croix Rousse LYON FRANCE | Hôpital de la Croix-Rousse | Hopital Psychiatrique De La Croix | Joseph Dib | Service des maladies infectieuses et tropicales, Hôpital de la Croix Rousse, Hospices Civils de Lyon

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aggression (Phase 4)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Emergencies (Phase 4)

Heart Failure (Phase 4)

Hepatitis (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

HIV Infections (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 11